Natus to Present at 30th Annual Roth Conference
Mar 05, 2018 12:00 pm UTC| Business
PLEASANTON, Calif., March 05, 2018 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer will present and Jonathan Kennedy, Executive Vice-President and...
RioCan launches new residential brand RioCan Living
Mar 05, 2018 12:00 pm UTC| Business
TORONTO, March 05, 2018 -- RioCan REIT ("RioCan") (TSX:REI.UN), announced today its new residential brand, RioCan Living™, as it capitalizes on and unlocks the intrinsic value of the company’s vast portfolio of major...
Amedisys Closes on Acquisition Adding Coverage Area in Western Kentucky
Mar 05, 2018 12:00 pm UTC| Business
BATON ROUGE, La., March 05, 2018 -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice and personal care companies, announced today that it has acquired the right to operate in 10...
CCUR Holdings, Inc. Receives NASDAQ Listing Extension; Approves Share Repurchase Program
Mar 05, 2018 12:00 pm UTC| Business
ATLANTA, March 05, 2018 -- CCUR Holdings, Inc. (NASDAQ:CCUR) (the “Company”) announced today that it received an extension for continued listing on The Nasdaq Stock Market through May 15, 2018 to demonstrate to the...
Mar 05, 2018 12:00 pm UTC| Business
MALVERN, Pa., March 05, 2018 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today announced an Industry...
Akoustis to Present at the 30th Annual Roth Conference at 4:30 pm ET on March 12th
Mar 05, 2018 12:00 pm UTC| Business
Charlotte, NC, March 05, 2018 -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented single-crystal BulkONE® bulk acoustic wave (BAW) high-band RF filters for...
XOMA to Present at the Cowen and Company 38th Annual Health Care Conference
Mar 05, 2018 12:00 pm UTC| Business
EMERYVILLE, Calif., March 05, 2018 -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced that Jim Neal, Chief Executive Officer, will present...